Locus Biosciences
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
8
Funding Rounds
$117.5m
Money raised
Overview
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
-
Websites:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Locus Biosciences has raised a total of $59m in funding over 8 rounds.
Key Insights:
- Locus Biosciences Series B round, May 18, 2022: $35m
- Locus Biosciences Series A round, November 2017: $19m
- Lous Biosciences , July 2017: $5m
- Locus Biosciences Venture round, April 2020: $20m
- Locus Biosciences Grant (money), November 2020: $12.5m
- Locus Biosciences Series A Funding Round November 2017: $19m
- Locus Biosciences Series A Funding Round July 2018: $7m
- Locus Biosciences Grant (money), August 2020: $3k
Locus Biosciences Series B round, May 18, 2022
$35m
Locus Biosciences Series A round, November 2017
$19m
Lous Biosciences , July 2017
$5m
Locus Biosciences Venture round, April 2020
$20m
Locus Biosciences Grant (money), November 2020
$12.5m
Locus Biosciences Grant (money), August 2020
$3k
Locus Biosciences Series A Funding Round November 2017
$19m
Locus Biosciences Series A Funding Round July 2018
$7m
Industries
Locus Biosciences is active in the following industries: